Exercise of Nil Cost Options under PSP

Assura

23/07/2025 09:30

RNS Number : 2320S

Assura PLC

23 July 2025

 

23 July 2025

 

Assura plc

("the Company")

Exercise of Nil Cost Options under PSP

The Company announces that on 22 July 2025, the PDMRs listed below exercised their 2022 PSP awards.

The table below shows the number of shares vesting, the number of shares sold to satisfy income tax and national insurance liabilities and the number of shares received following the sales.

Number of shares awarded
Number of shares sold to satisfy income tax and national insurance liabilities
Additional shares sold
Number of shares after shares sold
Jonathan Murphy
344,426
161,880
-
182,546
Jayne Cottam
200,490
94,230
-
106,260
Orla Ball
62,964
29,593
33,371
-
Rob James
80,135
37,663
42,472
-

 

The Remuneration Committee of Assura had agreed that sufficient shares may be sold by each PDMR to cover the arising income tax and national insurance liabilities and that Ms Ball and Mr James could sell the balances of their restricted shares in full. The relevant market price for taxation purposes is £0.5025 per share.

As a result of the above, the PDMR's shareholding and those of their connected persons is as follows:

Shareholding on
21 July 2025
Shareholding
post exercise
Jonathan Murphy
3,335,217
3,517,763
Jayne Cottam
960,362
1,066,622
Orla Ball
47,060
47,060
Rob James
37,667
37,667

 

Following the allotment, Mr Murphy and Ms Cottam transferred 182,546 and 106,260 shares respectively to their spouses. The total beneficial holding remains the same.

The Notification of Dealing Form for each PDMR can be found below.

This notification is made in accordance with the Market Abuse Regulation.

 

Notification of dealing form

1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Jonathan Murphy
2
Reason for the notification
a)
Position/status
CEO
b)
Initial notification/ Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Assura plc
b)
LEI
21380026T19N2Y52XF72
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 10 pence each
GB00BVGBWW93
b)
Nature of the transaction
Vesting of share awards under PSP
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£Nil GBP
344,426
d)
Aggregated information
- Aggregated volume
- Price
N/A
e)
Date of the transaction
22 July 2025
f)
Place of the transaction
XLON
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 10 pence each
GB00BVGBWW93
b)
Nature of the transaction
Sale of shares to satisfy tax and national insurance liabilities
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£0.5025 GBP
161,880
d)
Aggregated information
- Aggregated volume
- Price
Aggregate Price
Aggregate Volume
Aggregate Total
£0.5025 GBP
161,880
£81,344.70 GBP
e)
Date of the transaction
22 July 2025
f)
Place of the transaction
XLON
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 10 pence each
GB00BVGBWW93
b)
Nature of the transaction
Transfer of shares to spouse
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£0.5025 GBP
182,546
d)
Aggregated information
- Aggregated volume
- Price
Aggregate Price
Aggregate Volume
Aggregate Total
£0.5025 GBP
182,546
£91,729.37 GBP
e)
Date of the transaction
22 July 2025
f)
Place of the transaction
XLON

 

 

1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Jayne Cottam
2
Reason for the notification
a)
Position/status
CFO
b)
Initial notification/ Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Assura plc
b)
LEI
21380026T19N2Y52XF72
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 10 pence each
GB00BVGBWW93
b)
Nature of the transaction
Vesting of share awards under PSP
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£Nil GBP
200,490
d)
Aggregated information
- Aggregated volume
- Price
N/A
e)
Date of the transaction
22 July 2025
f)
Place of the transaction
XLON
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 10 pence each
GB00BVGBWW93
b)
Nature of the transaction
Sale of shares to satisfy tax and national insurance liabilities
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£0.5025 GBP
94,230
d)
Aggregated information
- Aggregated volume
- Price
Aggregate Price
Aggregate Volume
Aggregate Total
£0.5025 GBP
94,230
£47,350.58 GBP
e)
Date of the transaction
22 July 2025
f)
Place of the transaction
XLON
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 10 pence each
GB00BVGBWW93
b)
Nature of the transaction
Transfer of shares to spouse
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£0.5025 GBP
106,260
d)
Aggregated information
- Aggregated volume
- Price
Aggregate Price
Aggregate Volume
Aggregate Total
£0.5025 GBP
106,260
£53,395.65 GBP
e)
Date of the transaction
22 July 2025
f)
Place of the transaction
XLON

 

 

1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Orla Ball
2
Reason for the notification
a)
Position/status
General Counsel
b)
Initial notification/ Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Assura plc
b)
LEI
21380026T19N2Y52XF72
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 10 pence each
GB00BVGBWW93
b)
Nature of the transaction
Vesting of restricted share awards under PSP
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£Nil GBP
62,964
d)
Aggregated information
- Aggregated volume
- Price
N/A
e)
Date of the transaction
22 July 2025
f)
Place of the transaction
XLON
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 10 pence each
GB00BVGBWW93
b)
Nature of the transaction
Sale of shares to satisfy tax and national insurance liabilities
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£0.5025 GBP
29,593
d)
Aggregated information
- Aggregated volume
- Price
Aggregate Price
Aggregate Volume
Aggregate Total
£0.5025 GBP
29,593
£14,870.48 GBP
e)
Date of the transaction
22 July 2025
f)
Place of the transaction
XLON
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 10 pence each
GB00BVGBWW93
b)
Nature of the transaction
Sale of shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£0.5025 GBP
33,371
d)
Aggregated information
- Aggregated volume
- Price
Aggregate Price
Aggregate Volume
Aggregate Total
£0.5025 GBP
33,371
£16,768.93 GBP
e)
Date of the transaction
22 July 2025
f)
Place of the transaction
XLON

 

1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Rob James
2
Reason for the notification
a)
Position/status
Group Development Director
b)
Initial notification/ Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Assura plc
b)
LEI
21380026T19N2Y52XF72
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 10 pence each
GB00BVGBWW93
b)
Nature of the transaction
Vesting of restricted share awards under PSP
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£Nil GBP
80,135
d)
Aggregated information
- Aggregated volume
- Price
N/A
e)
Date of the transaction
22 July 2025
f)
Place of the transaction
XLON
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 10 pence each
GB00BVGBWW93
b)
Nature of the transaction
Sale of shares to satisfy tax and national insurance liabilities
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£0.5025 GBP
37,663
d)
Aggregated information
- Aggregated volume
- Price
Aggregate Price
Aggregate Volume
Aggregate Total
£0.5025 GBP
37,663
£18,910.58 GBP
e)
Date of the transaction
22 July 2025
f)
Place of the transaction
XLON
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 10 pence each
GB00BVGBWW93
b)
Nature of the transaction
Sale of shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£0.5025 GBP
42,272
d)
Aggregated information
- Aggregated volume
- Price
Aggregate Price
Aggregate Volume
Aggregate Total
£0.5025 GBP
42,272
£21,241.68 GBP
e)
Date of the transaction
22 July 2025
f)
Place of the transaction
XLON

 

 

 

For more information, please contact:

Assura plc
Tel:0161 515 2043
David Purcell, Investor Relations Director
Email:Investor@assura.co.uk
FGS Global
Gordon Simpson
Tel:0207 251 3801
Email:Assura@fgsglobal.com

 

Notes to Editors

Assura plc is the UK's leading diversified healthcare REIT. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served.

A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA* indices and has a secondary listing on the Johannesburg Stock Exchange.

At Assura we BUILD for health and as the first FTSE 250 certified B Corp we are committed to keeping ESG at the heart of our strategy, creating Healthy Environments (E) and Healthy Communities (S) and maintaining a Healthy Business (G).

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHPPUUGMUPAURW